Lista de obras - Elisabetta Bugianesi - Dominio Público Uruguay

A "systems medicine" approach to the study of non-alcoholic fatty liver disease

artículo científico publicado en 2015

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

artículo científico publicado en 2005

Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease

artículo científico publicado en 2019

Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease

artículo científico publicado en 2009

Adiponectin isoforms, insulin resistance and liver histology in nonalcoholic fatty liver disease

artículo científico publicado en 2010

Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology

artículo científico publicado en 2020

Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance

artículo científico publicado en 2017

Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection

artículo científico publicado en 2020

Changes in Liver Stiffness and Markers of Liver Synthesis and Portal Hypertension following Hepatitis C Virus Eradication in Cirrhotic Individuals

artículo científico publicado en 2022

Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report

artículo científico publicado en 2020

Complex non‐invasive fibrosis models are more accurate than simple models in non‐alcoholic fatty liver disease ⬇️

artículo científico publicado el 1 de octubre de 2011

Corrigendum to “Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis” [Dig. Liver Dis. 44 (2012) 334–342]

scholarly article published in Digestive and Liver Disease

Cross Talk between Gut Microbiota and Immune System: From Pathophysiology to Potential Therapeutic Interventions in Inflammatory Bowel Disease

artículo científico publicado en 2024

Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

artículo científico publicado en 2023

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

artículo científico publicado en 2021

Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load

artículo científico publicado en 2016

Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes

artículo científico publicado en 2016

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action?

artículo científico publicado en 2016

Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2012

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease

artículo científico publicado en 2005

Estimates of hepatic glyceroneogenesis in type 2 diabetes mellitus in humans

artículo científico publicado en 2008

Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014.

scientific article published on September 2016

FibroGENE: A gene-based model for staging liver fibrosis

artículo científico publicado en 2015

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

artículo científico publicado en 2006

From the metabolic syndrome to NAFLD or vice versa?

artículo científico publicado en 2010

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

artículo científico publicado en 2017

Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease ⬇️

artículo científico publicado el 1 de marzo de 2012

Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease

artículo científico publicado en 2014

HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas

artículo científico publicado en 2011

HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2009

Hepatic and cardiac steatosis: are they coupled?

artículo científico publicado en 2012

Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?

artículo científico publicado en 2013

IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection

artículo científico publicado en 2014

Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development

artículo científico publicado en 2023

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease

artículo científico publicado en 2016

Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study

artículo científico publicado en 2008

Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies

artículo científico publicado en 2023

Insulin resistance: a metabolic pathway to chronic liver disease

artículo científico publicado en 2005

Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P

scientific article published on 22 November 2020

Is liver disease a threat to patients with metabolic disorders?

artículo científico publicado en 2005

Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis

artículo científico publicado en 2015

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.

artículo científico publicado en 2016

Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis

artículo científico publicado en 2017

NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes

artículo científico publicado en 2007

Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease

artículo científico publicado en 2013

Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment

artículo científico publicado en 2004

Non-alcoholic steatohepatitis in patients cared in metabolic units

artículo científico publicado en 2004

Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data

artículo científico publicado en 2015

Nonalcoholic fatty liver disease and the metabolic syndrome

artículo científico publicado en 2005

Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?

artículo científico publicado en 2016

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

artículo científico publicado en 2003

Obesity and liver cancer

artículo científico

Obesity: Childhood obesity: time bomb for future burden of chronic liver disease

artículo científico publicado en 2016

On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases

scientific article published on 15 March 2020

Pathophysiology of Non Alcoholic Fatty Liver Disease

artículo científico publicado en 2016

Paul Angulo: Clinician investigator

artículo científico publicado en 2015

Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease

artículo científico publicado en 2015

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

artículo científico publicado en 2005

Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States

Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma

scientific article published on 28 September 2020

Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver Disease

artículo científico publicado en 2023

Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults

artículo científico publicado en 2015

Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease.

artículo científico publicado en 2018

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

artículo científico publicado en 2004

Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis ⬇️

artículo científico publicado el 21 de agosto de 2010

Reply to "Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs?".

artículo científico publicado en 2016

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity

artículo científico publicado en 2010

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

artículo científico publicado en 2008

SIGNIFICANT IMPROVEMENT OF GLYCAEMIC CONTROL IN DIABETIC PATIENTS WITH HCV INFECTION RESPONDING TO DIRECT-ACTING ANTIVIRAL AGENTS.

artículo científico publicado en 2017

Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2013

Should we undertake surveillance for HCC in patients with NAFLD?

artículo científico publicado en 2017

Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis.

artículo científico publicado en 2011

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

scientific article published on 13 July 2013

Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease

artículo científico publicado en 2012

Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander

artículo científico

The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease

artículo científico publicado en 2023

The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study

scientific article published on 04 December 2020

The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2014

The interaction of metabolic factors with HCV infection: Does it matter? ⬇️

artículo científico publicado el 1 de enero de 2012

Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?

artículo científico publicado en 2016

Type 2 diabetes mellitus and chronic hepatitis C: which is worse? Results of a long-term retrospective cohort study

artículo científico publicado en 2012

Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis

artículo científico publicado en 2013

Undernutrition, risk of malnutrition and obesity in gastroenterological patients: A multicenter study

artículo científico publicado en 2016

Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study

artículo científico publicado en 2017

Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study

artículo científico publicado en 2017

in Inflammatory Bowel Diseases: Active Protagonist or Innocent Bystander?

artículo científico publicado en 2024

Lista de obras de Elisabetta Bugianesi

A "systems medicine" approach to the study of non-alcoholic fatty liver disease

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease

Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease

Adiponectin isoforms, insulin resistance and liver histology in nonalcoholic fatty liver disease

Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology

Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance

Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection

Changes in Liver Stiffness and Markers of Liver Synthesis and Portal Hypertension following Hepatitis C Virus Eradication in Cirrhotic Individuals

Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report

Complex non‐invasive fibrosis models are more accurate than simple models in non‐alcoholic fatty liver disease ⬇️

Corrigendum to “Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis” [Dig. Liver Dis. 44 (2012) 334–342]

Cross Talk between Gut Microbiota and Immune System: From Pathophysiology to Potential Therapeutic Interventions in Inflammatory Bowel Disease

Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load

Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action?

Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease

Estimates of hepatic glyceroneogenesis in type 2 diabetes mellitus in humans

Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014.

FibroGENE: A gene-based model for staging liver fibrosis

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

From the metabolic syndrome to NAFLD or vice versa?

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease ⬇️

Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease

HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas

HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease

Hepatic and cardiac steatosis: are they coupled?

Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?

IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection

Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease

Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study

Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies

Insulin resistance: a metabolic pathway to chronic liver disease

Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P

Is liver disease a threat to patients with metabolic disorders?

Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.

Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis

NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes

Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease

Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment

Non-alcoholic steatohepatitis in patients cared in metabolic units

Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data

Nonalcoholic fatty liver disease and the metabolic syndrome

Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

Obesity and liver cancer

Obesity: Childhood obesity: time bomb for future burden of chronic liver disease

On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases

Pathophysiology of Non Alcoholic Fatty Liver Disease

Paul Angulo: Clinician investigator

Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States

Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma

Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver Disease

Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults

Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease.

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis ⬇️

Reply to "Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs?".

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

SIGNIFICANT IMPROVEMENT OF GLYCAEMIC CONTROL IN DIABETIC PATIENTS WITH HCV INFECTION RESPONDING TO DIRECT-ACTING ANTIVIRAL AGENTS.

Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver disease

Should we undertake surveillance for HCC in patients with NAFLD?

Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis.

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease

Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander

The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease

The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study

The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease

The interaction of metabolic factors with HCV infection: Does it matter? ⬇️